BiotechTube

Olanzapine, Amantadine + Olanzapine and placebo

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Psychotic Disorder

Conditions

Psychotic Disorder, Schizophreniform Disorder, Schizophrenia, Schizoaffective Disorder, Mood Disorders With Psychotic Features

Trial Timeline

May 1, 2005 → Sep 1, 2009

NCT ID
NCT00287352

About Olanzapine, Amantadine + Olanzapine and placebo

Olanzapine, Amantadine + Olanzapine and placebo is a phase 1 stage product being developed by Eli Lilly for Psychotic Disorder. The current trial status is completed. This product is registered under clinical trial identifier NCT00287352. Target conditions include Psychotic Disorder, Schizophreniform Disorder, Schizophrenia.

What happened to similar drugs?

2 of 7 similar drugs in Psychotic Disorder were approved

Approved (2) Terminated (4) Active (2)
❌quetiapineAstraZenecaPhase 3
🔄QuetiapineAstraZenecaPhase 3
❌QuetiapineAstraZenecaPhase 3
✅Asenapine 5-20 mg daily + Placebo 1-4 tablets dailyMerckApproved
✅Ziprasidone HCL (oral)PfizerApproved
🔄AripiprazoleBristol Myers SquibbPhase 3
❌mifepristone + placeboCorcept TherapeuticsPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00287352Phase 1Completed

Competing Products

14 competing products in Psychotic Disorder

See all competitors
ProductCompanyStageHype Score
risperidone IR and LAI formulationJohnson & JohnsonPhase 1
29
quetiapineAstraZenecaPhase 3
32
QuetiapineAstraZenecaPhase 3
40
QuetiapineAstraZenecaPhase 3
32
quetiapine + olanzapine + risperidoneAstraZenecaPre-clinical
26
Asenapine 5-20 mg daily + Placebo 1-4 tablets dailyMerckApproved
43
Ziprasidone HCL (oral)PfizerApproved
35
AripiprazoleBristol Myers SquibbPhase 3
40
Aripiprazole + Risperidone/QuetiapineBristol Myers SquibbPre-clinical
26
mifepristone + placeboCorcept TherapeuticsPhase 3
29
Miricorlilant + Miricorlilant + PlaceboCorcept TherapeuticsPhase 2
32
Miricorilant + FluvoxamineCorcept TherapeuticsPhase 1
26
Miricorilant + PlaceboCorcept TherapeuticsPhase 2
32
Olanzapine + CORT118335 + PlaceboCorcept TherapeuticsPhase 1
26